Sequence differences between α1C and α1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor

被引:25
作者
Berjukow, S [1 ]
Gapp, F [1 ]
Aczél, S [1 ]
Sinnegger, J [1 ]
Mitterdorfer, J [1 ]
Glossmann, H [1 ]
Hering, S [1 ]
机构
[1] Inst Biochem Pharmacol, A-6020 Innsbruck, Austria
关键词
D O I
10.1074/jbc.274.10.6154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular basis of the Ca2+ channel block by (+)cis-diltiazem was studied in class A/L-type chimeras and mutant ore. Ca2+ channels. Chimeras consisted of either rabbit heart (alpha(1C-a)) or carp skeletal muscle (alpha(1S)) sequence in transmembrane segments IILS6, IVS6, and adjacent S5-S6 linkers. Only chimeras containing sequences from alpha(1C-a) were efficiently blocked by (+)-cis-diltiazem, whereas the phenylalkylamine (-)-gallopamil efficiently blocked both constructs. Carp skeletal muscle and rabbit heart Ca2+ channel alpha(1) subunits differ with respect to two nonconserved amino acids in segments IVS6. Transfer of a single leucine (Leu(1383), located at the extracellular mouth of the pore) from IVS6 alpha(1C-a) to IVS6 of alpha(1S) Significantly increased the (+)-cis-diltiazem sensitivity of the corresponding mutant L1383I. An analysis of the role of the two heterologous amino acids in a L-type alpha(1) subunit revealed that corresponding amino acids in position 1487 (outer channel mouth) determine recovery of resting Ca2+ channels from block by (+)-cis-diltiazem. The second heterologous amino acid in position 1504 of segment IVS6 (inner channel mouth) was identified as crucial inactivation determinant of L-type Ca2+ channels. This residue simultaneously modulates drug binding during membrane depolarization. Our study provides the first evidence for a guarded and modulated benzothiazepine receptor on L-type channels.
引用
收藏
页码:6154 / 6160
页数:7
相关论文
共 32 条
  • [1] Barrish J C, 1993, Bioorg Med Chem, V1, P309, DOI 10.1016/S0968-0896(00)82135-5
  • [2] Extra- and intracellular action of quaternary devapamil on muscle L-type Ca2+-channels
    Berjukov, S
    Aczel, S
    Beyer, B
    Kimball, SD
    Dichtl, M
    Hering, S
    Striessnig, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) : 1197 - 1202
  • [3] THE NAMING OF VOLTAGE-GATED CALCIUM CHANNELS
    BIRNBAUMER, L
    CAMPBELL, KP
    CATTERALL, WA
    HARPOLD, MM
    HOFMANN, F
    HORNE, WA
    MORI, Y
    SCHWARTZ, A
    SNUTCH, TP
    TANABE, T
    TSIEN, RW
    [J]. NEURON, 1994, 13 (03) : 505 - 506
  • [4] Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels - Critical involvement of tyrosine residues in motif IIIS6 and IVS6
    Bodi, I
    Yamaguchi, H
    Hara, M
    He, M
    Schwartz, A
    Varadi, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 24952 - 24960
  • [5] Inhibition of recombinant Ca2+ channels by benzothiazepines and phenylalkylamines: Class-specific pharmacology and underlying molecular determinants
    Cai, DM
    Mulle, JG
    Yue, DT
    [J]. MOLECULAR PHARMACOLOGY, 1997, 51 (05) : 872 - 881
  • [6] Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site
    Degtiar, VE
    Aczel, S
    Doring, F
    Timin, EN
    Berjukow, S
    Kimball, D
    Mitterdorfer, J
    Hering, S
    [J]. BIOPHYSICAL JOURNAL, 1997, 73 (01) : 157 - 167
  • [7] Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha(1A)
    Doring, F
    Degtiar, VE
    Grabner, M
    Striessnig, J
    Hering, S
    Glossmann, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (20) : 11745 - 11749
  • [8] Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels
    Grabner, M
    Wang, ZY
    Hering, S
    Striessnig, J
    Glossmann, H
    [J]. NEURON, 1996, 16 (01) : 207 - 218
  • [9] CALCIUM CHANNELS FROM CYPRINUS-CARPIO SKELETAL-MUSCLE
    GRABNER, M
    FRIEDRICH, K
    KNAUS, HG
    STRIESSNIG, J
    SCHEFFAUER, F
    STAUDINGER, R
    KOCH, WJ
    SCHWARTZ, A
    GLOSSMANN, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (03) : 727 - 731
  • [10] HERING S, 1993, MOL PHARMACOL, V43, P820